Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Aripiprazole for treating irritability in children & adolescents with autism: a systematic review
Aripiprazole in the treatment of depression: a review
Aripiprazole and Neuroleptic Malignant Syndrome in an Adolescent Patient: A Case Report
Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD
Aripiprazole augmentation for the treatment of an adolescent with posttraumatic stress disorder
Aripiprazole-Related Subcortical Growth in a Patient With Major Depressive Disorder and Panic Disorder
Aripiprazole-Induced Gray Matter Growth in a Patient With Major Depressive Disorder With Panic Disorder
Aripiprazole as a Viable Alternative for Treating Delusions of Parasitosis
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study
Aripiprazole in Pregnancy and Lactation A Case Report
Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder A Critical Review by an Italian Working Group
Aripiprazole monotherapy in a patient with major depressive disorder
Aripiprazole use in children and adolescents: a case series
Aripiprazole for late-life schizophrenia
Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence
Aripiprazole Treatment for Coprophagia in Autistic Disorder
Aripiprazole in Schizophrenia and Schizoaffective Disorder: A Review
Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting
Aripiprazole Add-On Treatment in a Patient with Schizoaffective Disorder: Neurocognitive Outcomes
Aripiprazole long-acting injection: promising but more evidence needed
Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy
Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives
Aripiprazole can a Viable Choice for Persistant Suppression of Symptoms in Managing Chronic Tic Disorders and Tourette's Disorder Through the Life Span: A Case Series
Aripiprazole loaded poly(caprolactone) nanoparticles: Optimization and in vivo pharmacokinetics
Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders
Aripiprazole-Associated Hypoprolactinemia in the Clinical Setting
Aripiprazole for autism spectrum disorders (ASD)
Aripiprazole and Haloperidol Activate GSK3 beta-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats
Aripiprazole Increases the PKA Signalling and Expression of the GABA(A) Receptor and CREB1 in the Nucleus Accumbens of Rats
Aripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disorders
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: Implication for antioxidative psychotropic actions via microglia
Aripiprazole joins the family of second-generation mood stabilizers
Aripiprazole versus olanzapine in the treatment of schizophrenia: A clinical study from India
Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
Aripiprazole, alcohol and substance abuse: a review
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
Aripiprazole in Treatment-Refractory Schizophrenia
Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study
Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial
Aripiprazole induced hypersexuality in a 24-year-old female patient with schizoaffective disorder?
Aripiprazole for the Treatment of Tourette Syndrome A Case Series of 100 Patients
Aripiprazole in Children with Tourette%26apos;s Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Aripiprazole in pregnancy: a review of literature
Aripiprazole (ABILIFY MAINTENA (R)): A Review of Its Use as Maintenance Treatment for Adult Patients with Schizophrenia
Aripiprazole Augmentation Treatment in Treatment Resistant Bipolar Depression: Two Patient Reports
Aripiprazole in the acute and maintenance phase of bipolar I disorder
Aripiprazole for Sexually Inappropriate Vocalizations in Frontotemporal Dementia
Aripiprazole A Review of its Use in the Management of Mania in Adults with Bipolar I Disorder
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients
Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder Overview and Implications of Clinical Trial Data
Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness
Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects
Aripiprazole and Ropinirole Treatment for Cocaine Dependence: Evidence from a Pilot Study
Aripiprazole protects cortical neurons from glutamate toxicity
Aripiprazole for the treatment of bipolar disorder: a review of current evidence
Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms
Aripiprazole A Review of its Use in the Management of Schizophrenia in Adults
Aripiprazole Use in Children and Adolescent Psychiatric Patients
Aripiprazole monotherapy in non-psychotic bipolar I depression
Aripiprazole in the treatment of depressive and anxiety disorders: A review of current evidence
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta- analysis of randomized controlled trials
Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study
Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment
Aripiprazole versus haloperidol treatment in early-stage schizophrenia
Aripiprazole versus other atypical antipsychotics for schizophrenia
Aripiprazole Effects on Self-Administration and Pharmacodynamics of Intravenous Cocaine and Cigarette Smoking in Humans
Aripiprazole: A Review of Its Use in the Treatment of Manic Episodes in Adolescents with Bipolar I Disorder
Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study
Aripiprazole in pediatric psychosis and bipolar disorder: A clinical review
Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals
Aripiprazole Augmentation in Clozapine-Associated Obsessive-Compulsive Symptoms
Aripiprazole Augmentation in 39 Adolescents With Medication-Resistant Obsessive-Compulsive Disorder
Aripiprazole in the treatment of primary delusional parasitosis
Aripiprazole in the treatment of primary delusional parasitosis - Reply
Aripiprazole - a medical treatment alternative for Tourette Syndrome in childhood and adolescence
Aripiprazole Induced Acute Dystonia After Discontinuation of a Stimulant Medication
Aripiprazole-induced tardive dyskinesia treated with quetiapine: a case report
Aripiprazole in Anorexia Nervosa and Low-Weight Bulimia Nervosa: Case Reports